These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30815157)

  • 61. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
    Berman SB; Miller-Patterson C
    Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease.
    Spetsieris PG; Eidelberg D
    Neuroimage; 2021 Feb; 226():117568. PubMed ID: 33246128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential White Matter Regional Alterations in Motor Subtypes of Early Drug-Naive Parkinson's Disease Patients.
    Wen MC; Heng HSE; Lu Z; Xu Z; Chan LL; Tan EK; Tan LCS
    Neurorehabil Neural Repair; 2018 Feb; 32(2):129-141. PubMed ID: 29347868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predicting the progression of Parkinson's disease using conventional MRI and machine learning: An application of radiomic biomarkers in whole-brain white matter.
    Shu ZY; Cui SJ; Wu X; Xu Y; Huang P; Pang PP; Zhang M
    Magn Reson Med; 2021 Mar; 85(3):1611-1624. PubMed ID: 33017475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Morphological Characterization of Functional Brain Imaging by Isosurface Analysis in Parkinson's Disease.
    Castillo-Barnes D; Martinez-Murcia FJ; Ortiz A; Salas-Gonzalez D; RamÍrez J; Górriz JM
    Int J Neural Syst; 2020 Sep; 30(9):2050044. PubMed ID: 32787634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deep learning architectures for Parkinson's disease detection by using multi-modal features.
    Pahuja G; Prasad B
    Comput Biol Med; 2022 Jul; 146():105610. PubMed ID: 35659446
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exploring diagnosis and imaging biomarkers of Parkinson's disease via iterative canonical correlation analysis based feature selection.
    Liu L; Wang Q; Adeli E; Zhang L; Zhang H; Shen D
    Comput Med Imaging Graph; 2018 Jul; 67():21-29. PubMed ID: 29702348
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of deep learning-based radiomics to differentiate Parkinson's disease patients from normal controls: a study based on [
    Sun X; Ge J; Li L; Zhang Q; Lin W; Chen Y; Wu P; Yang L; Zuo C; Jiang J
    Eur Radiol; 2022 Nov; 32(11):8008-8018. PubMed ID: 35674825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a prospective early motor progression cluster of Parkinson's disease: Data from the PPMI study.
    Vavougios GD; Doskas T; Kormas C; Krogfelt KA; Zarogiannis SG; Stefanis L
    J Neurol Sci; 2018 Apr; 387():103-108. PubMed ID: 29571843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An adaptive weighted attention-enhanced deep convolutional neural network for classification of MRI images of Parkinson's disease.
    Cui X; Chen N; Zhao C; Li J; Zheng X; Liu C; Yang J; Li X; Yu C; Liu J; Liu X
    J Neurosci Methods; 2023 Jul; 394():109884. PubMed ID: 37207799
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene-related Parkinson's disease diagnosis via feature-based multi-branch octave convolution network.
    Lei H; Zhang Y; Li H; Huang Z; Liu CH; Zhou F; Tan EL; Xiao X; Lei Y; Hu H; Huang Y; Lei B
    Comput Biol Med; 2022 Sep; 148():105859. PubMed ID: 35930956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid motor progression of Parkinson's disease associates with clinical and genetic variants.
    Cao LX; Jiang Y; Piao YS; Huang Y
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1503-1512. PubMed ID: 34994165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An individualized prediction of time to cognitive impairment in Parkinson's disease: A combined multi-predictor study.
    Tang C; Zhao X; Wu W; Zhong W; Wu X
    Neurosci Lett; 2021 Sep; 762():136149. PubMed ID: 34352339
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parkinson's Progression Markers Initiative brain autopsy program.
    Bukhari SA; Nudelman KNH; Rumbaugh M; Richeson P; Fox EJ; Montine KS; Aldecoa I; Garrido A; Franz J; Stadelmann C; Vonsattel JPG; Poston KL; Foroud TM; Montine TJ;
    Parkinsonism Relat Disord; 2022 Aug; 101():62-65. PubMed ID: 35803091
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease.
    Glaab E; Trezzi JP; Greuel A; Jäger C; Hodak Z; Drzezga A; Timmermann L; Tittgemeyer M; Diederich NJ; Eggers C
    Neurobiol Dis; 2019 Apr; 124():555-562. PubMed ID: 30639291
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multi-task SCCA method for brain imaging genetics and its application in neurodegenerative diseases.
    Zhang X; Hao Y; Zhang J; Ji Y; Zou S; Zhao S; Xie S; Du L
    Comput Methods Programs Biomed; 2023 Apr; 232():107450. PubMed ID: 36905750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TE-HI-GCN: An Ensemble of Transfer Hierarchical Graph Convolutional Networks for Disorder Diagnosis.
    Li L; Jiang H; Wen G; Cao P; Xu M; Liu X; Yang J; Zaiane O
    Neuroinformatics; 2022 Apr; 20(2):353-375. PubMed ID: 34761367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.